Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  IRadimed Corporation    IRMD

IRADIMED CORPORATION

(IRMD)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/24/2020 03/25/2020 03/26/2020 03/27/2020 03/30/2020 Date
20(c) 19.53(c) 19.54(c) 18.67(c) 19.195 Last
22 068 47 810 56 337 88 021 770 Volume
+12.55% -2.35% +0.05% -4.45% +2.81% Change
More quotes
Financials (USD)
Sales 2020 46,7 M
EBIT 2020 12,3 M
Net income 2020 9,50 M
Debt 2020 -
Yield 2020 -
Sales 2021 57,1 M
EBIT 2021 19,4 M
Net income 2021 14,6 M
Debt 2021 -
Yield 2021 -
P/E ratio 2020 24,6x
P/E ratio 2021 16,5x
Capi. / Sales2020 4,76x
Capi. / Sales2021 3,90x
Capitalization 223 M
More Financials
Company
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV... 
More about the company
Latest news on IRADIMED CORPORATION
03/12IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice Presi..
GL
03/06IRADIMED : to Present at the 32nd Annual Roth Conference
AQ
03/06IRADIMED : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
02/26IRADIMED CORP : Change in Directors or Principal Officers, Financial Statements ..
AQ
02/26IRADIMED CORPORATION Announces Retirement of Francis Casey and the Appointmen..
GL
02/06IRADIMED : 4Q Earnings Snapshot
AQ
02/06IRADIMED CORP : Results of Operations and Financial Condition, Financial Stateme..
AQ
02/06IRADIMED CORPORATION Announces Fourth Quarter 2019 Financial Results
GL
01/22IRADIMED CORPORATION to Hold 2019 Fourth Quarter Financial Results Conference..
GL
01/07IRADIMED CORP : Change in Directors or Principal Officers, Financial Statements ..
AQ
01/07IRADIMED CORPORATION Announces Retirement of Brent Johnson and the Appointmen..
GL
2019IRADIMED : CE Mark Renewal Process MRI Compatible Patient Vital Signs Monitoring..
AQ
2019IRADIMED CORP : Other Events (form 8-K)
AQ
2019IRADIMED : Completes CE Mark Renewal Process For Its MRI Compatible Patient Vita..
AQ
2019IRADIMED : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
More news
News in other languages on IRADIMED CORPORATION

- No features available -

More news
Chart IRADIMED CORPORATION
Duration : Period :
IRadimed Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IRADIMED CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 32,00  $
Last Close Price 18,67  $
Spread / Highest target 71,4%
Spread / Average Target 71,4%
Spread / Lowest Target 71,4%
EPS Revisions
Managers
NameTitle
Leslie McDonnell President, Chief Executive Officer & Director
Roger Susi Chairman & Chief Technology Officer
Christopher K. Scott Chief Financial Officer & Secretary
Lynn Neuhardt Vice President-Research & Development
James B. Hawkins Director
Sector and Competitors
1st jan.Capitalization (M$)
IRADIMED CORPORATION-20.15%223
ABBOTT LABORATORIES-14.16%131 482
MASIMO CORPORATION13.27%9 631
NOVOCURE LIMITED-22.27%6 526
ASAHI INTECC CO., LTD.-8.89%6 501
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.0.52%5 383